TNF‐α blockade may lead to improvement of vascular function in psoriasis patients

Psoriasis is one of the most common chronic inflammatory skin diseases and at the same time a risk factor for cardiovascular disease. Interleukin‐17A (IL‐17A)–mediated inflammation in psoriasis may lead to vascular dysfunction. This study aimed at investigating whether anti‐inflammatory treatment by tumor necrosis factor (TNF)‐α blockade alters vascular function in psoriasis patients. A total of 11 patients with psoriasis who underwent treatment...